Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02331979 · ClinicalTrials.gov registry record · NA

Improving Bladder Function in SCI by Neuromodulation

A NA study of Spinal Cord Injury, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT02331979: Recruiting NA study of Spinal Cord Injury, sponsored by University of California, Los Angeles.

NCT02331979 is a NA study of Spinal Cord Injury that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 24 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02331979, a NA study of Spinal Cord Injury, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury.

Conditions Studied

Interventions

  • DEVICE Electromagnetic Neuromodulation

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2015-09
Est. Completion 2027-01-31
Phase NA

What NCT02331979 shows while recruiting

NCT02331979 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Electromagnetic Neuromodulation is the first listed.

NCT02331979 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02331979 about?

NCT02331979 is a clinical study titled "Improving Bladder Function in SCI by Neuromodulation". This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury.

What is the current status of trial NCT02331979?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2015-09. Estimated completion is 2027-01-31.

What conditions does trial NCT02331979 study?

This clinical trial studies the following conditions: Spinal Cord Injury.

What interventions are being tested in trial NCT02331979?

The interventions under investigation include: Electromagnetic Neuromodulation (DEVICE).

Who is sponsoring clinical trial NCT02331979?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02331979 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02331979's enrollment target sits among peer trials

24 51st of 99 higher than 48 of 99 other Spinal Cord Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

  • NCT03437005 · 24 participants · Phase 1

    Alternation in the Human Microbiome With Commonly Used Topical Medications

  • NCT03452202 · 24 participants · NA

    Using tDCS in Speech-based Stroke Rehabilitation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02331979, the US trial registry maintained by the National Library of Medicine. NCT02331979 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.